Transcriptome-Wide Sequencing Reveals Molecules and Pathways Involved in Neurofibromatosis Type I Combined with Spinal Deformities.
This is a clinical basic study on NF1 with spinal deformity. The current research focuses on screening key molecules affecting NF1 with spinal deformity by transcriptome sequencing and discovering its underlying molecular biological mechanisms. Neurofibromatosis type I (NF-1) is a complex multi-system human disorder which is often found in spinal deformities patients. The success rate of orthopedic surgery for neurofibromatosis type I combined with spinal deformities patients was low because of the lack of molecular pathology. In our study, the transcriptome-wide sequencing was preformed to identify the differentially expressed genes (DEGs) involved in this disease. 780 DEGs were identified which include protein coding genes, miRNAs, and lncRNAs. The enrichment analysis may reveal pathways that these DEGs involved. And the 383 protein-pairs for DEGs that involved in NF-1 combined with spinal deformities may unfold the possible mechanism how this disease is developed. The DE miRNAs and lncRNAs may contribute the ceRNA network. We focused on three key DEGs: FGFR2, MAP3K1 and STAT4. FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway, and STAT4 were involved in the JAK/STAT pathway. The expression changes were verified by other researches and the functional cross-talk between the Ras/MAPK and JAK/STAT pathways may contribute in the disease development. This study took insight of the molecular mechanism of this disease. More detailed interactions between these factors are needed to be further explored. These key DEGs and involved pathways may provide clues in the clinical process for patients with NF1, especially in prognosis prediction. N/A.